Swiss TPH "The European Medicines Agency has adopted a positive opinion of fexinidazole for the treatment of T.b. rhodesiense sleeping sickness, found in Eastern and Southern Africa. The positive opinion is followed a clinical trial conducted by the HAT-r-ACC Consortium, of which Swiss TPH is a part. This is an important milestone in the fight against this acute and lethal form of the neglected tropical disease."
Deutschschweiz
Medicus Mundi Schweiz
Murbacherstrasse 34
CH-4056 Basel
Tel. +41 61 383 18 10
info@medicusmundi.ch
Suisse romande
Medicus Mundi Suisse
Rue de Varembé 1
CH-1202 Genève
Tél. +41 22 920 08 08
contact@medicusmundi.ch
Bankverbindung
Basler Kantonalbank, Aeschen, 4002 Basel
Medicus Mundi Schweiz, 4056 Basel
IBAN: CH40 0077 0016 0516 9903 5
BIC: BKBBCHBBXXX